Characterization of the mononuclear cell infiltrate in human malignant melanoma
- PMID: 1176196
- DOI: 10.1002/ijc.2910160108
Characterization of the mononuclear cell infiltrate in human malignant melanoma
Abstract
In the skin infiltrate of superficial spreading melanoma, non phagocytosing mononuclear cells (NPMC) represent a major cell component. The number of NPMCs decreases as a function of tumour progression. In addition, when an NPMC is in contact with a malignant melanocyte, the latter cell exhibits ultrastructural degenerative changes. In the blood of healthy donors and of melanoma patients, atypical mononuclear cells (AMC) can be identified. AMCs have been shown to participate in antibody-dependent cellular cytotoxicity (ADCC) reactions against melanoma cells in vitro. In this paper, it is reported that NPMCs and AMCs have in common their size, and some ultrastructural features such as indented nuclei, dispersed organelles, rough endoplasmic reticulum profiles and surface microvilli. The two cell types are negative for non-specific esterase. They also fail to react for peroxidase at either the light or the electron microscopic level. They do not adhere to glass. AMCs do not form spontaneous E rosettes, they have no surface IgG and they have no receptors for complement. However, they do form rosettes with EAIgG. On frozen sections firm binding of EAIgG has been seen on the skin infiltrate in three cases out of 10. It is concluded that NPMCs might react with tumour cells in vivo, in the same manner as do AMCs in vitro.
Similar articles
-
Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).J Immunol. 1975 Aug;115(2):539-48. J Immunol. 1975. PMID: 1171141
-
Human malignant melanoma. Melanosomal polymorphism and the ultrastructural dopa reaction.Br J Dermatol. 1978 Apr;98(4):381-90. Br J Dermatol. 1978. PMID: 638044
-
Human peripheral Nullymphocytes: ultrastructural aspects of the "K" cell effect against a melanoma target cell.Biomedicine. 1978 Jul-Aug;28(4):219-25. Biomedicine. 1978. PMID: 737273
-
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.Pigment Cell Melanoma Res. 2011 Apr;24(2):334-44. doi: 10.1111/j.1755-148X.2010.00799.x. Epub 2010 Nov 19. Pigment Cell Melanoma Res. 2011. PMID: 21029398 Review.
-
Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?Pigment Cell Res. 2005 Aug;18(4):234-42. doi: 10.1111/j.1600-0749.2005.00244.x. Pigment Cell Res. 2005. PMID: 16029417 Review.
Cited by
-
Local responses in primary and secondary human lung cancers. I. Patterns of cellular (eosinophils and macrophages) and extracellular (acid mucopolysaccharide) reactions.Br J Cancer. 1979 Sep;40(3):403-9. doi: 10.1038/bjc.1979.195. Br J Cancer. 1979. PMID: 159709 Free PMC article.
-
Cells bearing Fc receptors in human malignant solid tumours.Br J Cancer. 1982 Feb;45(2):201-8. doi: 10.1038/bjc.1982.34. Br J Cancer. 1982. PMID: 7059470 Free PMC article.
-
Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.Cancer Metastasis Rev. 1984;3(1):53-74. doi: 10.1007/BF00047693. Cancer Metastasis Rev. 1984. PMID: 6370420 Review.
-
Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.Br J Ophthalmol. 1980 Aug;64(8):576-90. doi: 10.1136/bjo.64.8.576. Br J Ophthalmol. 1980. PMID: 7426575 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources